Compare ROP & MDLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ROP | MDLN |
|---|---|---|
| Founded | 1981 | 1966 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.1B | 30.7B |
| IPO Year | 2002 | 2025 |
| Metric | ROP | MDLN |
|---|---|---|
| Price | $363.35 | $34.95 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 20 | 27 |
| Target Price | ★ $445.20 | $44.60 |
| AVG Volume (30 Days) | 632.9K | ★ 6.8M |
| Earning Date | 10-22-2026 | 08-05-2026 |
| Dividend Yield | ★ 1.04% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 16.35 | 0.23 |
| Revenue | $7,902,500,000.00 | ★ $28,432,000,000.00 |
| Revenue This Year | $8.21 | $9.85 |
| Revenue Next Year | $6.31 | $7.82 |
| P/E Ratio | ★ $21.45 | $151.74 |
| Revenue Growth | ★ 12.26 | 11.47 |
| 52 Week Low | $305.96 | $31.49 |
| 52 Week High | $521.24 | $50.88 |
| Indicator | ROP | MDLN |
|---|---|---|
| Relative Strength Index (RSI) | 34.53 | 53.04 |
| Support Level | $343.25 | $32.47 |
| Resistance Level | $364.24 | $37.39 |
| Average True Range (ATR) | 7.73 | 1.14 |
| MACD | -2.73 | 0.34 |
| Stochastic Oscillator | 17.74 | 85.78 |
Roper Technologies is a holding company focused on acquiring, managing, and developing niche market-leading technology businesses. The company operates a decentralized business model whereby each portfolio company operates independently from the others. Roper positions itself as a free cash flow compounder, whereby excess free cash flow generated by its portfolio businesses is repatriated to the parent company, which is then utilized to acquire additional businesses. Presently, the company operates 30 distinct businesses with over three-fourths of the revenue coming from software products and over two-thirds of revenue coming from recurring and reoccurring sources.
Medline is the largest provider of medical-surgical products and supply chain solutions in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front-line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.